CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 94 enrolled
Drug / intervention
Nicotine patch +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03492463
NCT03492463Phase 2Completed

The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products

Duke University·interventional·Posted Apr 10, 2018·Updated Feb 8, 2023

In Brief

A Phase 2 clinical trial evaluating Nicotine patch, Placebo patch, and 2 other interventions for Nicotine Dependence, Cigarettes. Completed, enrolled 94 participants across 1 site.

Detailed Summary

This study plans to investigate whether using electronic cigarettes (e-cigarettes) or skin patches containing nicotine affects switching from smoking conventional combustible (burning) cigarettes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedApr 10, 2018
Enrollment StartAug 6, 2018
Primary CompletionMay 31, 2021
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 8.2 years ago

Interventions

Nicotine patchdrug

Participants will wear the nicotine patch daily while switching from cigarette use to use of e-cigarettes for eight weeks.

Placebo patchother

Participants will wear the placebo patch daily while switching from cigarette use to use of e-cigarettes for eight weeks.

E-cigarettesother

Participants will use e-cigarettes containing nicotine while switching from cigarette use to use of e-cigarettes for eight weeks.

Non-nicotine e-cigarettesother

Participants will use e-cigarettes not containing nicotine while switching from cigarette use to use of e-cigarettes for eight weeks.